Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Permethrin cream: Two times topical application of five percent permethrin cream once a week
Control Intervention1: Tab Ivermectin: Tab Ivermectin 12mg oral route 2 tablets once a week.
Sponsors
Dr Anitha
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to give written informed consent 2. Patients of either sex aged 18 to 60 years 3. Patients diagnosed with uncomplicated scabies
Exclusion criteria
Exclusion criteria: 1. Patients with crusted scabies, secondary infections and its consequences like skin sores, septicemia, heart disease, chronic kidney disease. 2. Patients with history of epileptic fits, immunodeficiency and any other coexisting skin disease that could interfere with treatment evaluation. 3. Pregnant and lactating mothers 4. In addition, patients with history of known hypersensitivity to Ivermectin. 5. Psychiatric/ emotional disturbance in patients which could limit ability of patients to comply.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy will be assessed by : Clinical improvement in signs and symptoms such as, 1.Measuring reduction in the Pruritus with skin rash at week 1 and 2 2.Measuring reduction in skin lesions (change in the size, number and morphology) at week 1 and 2 Safety will be assessed by: Number and severity of adverse events.Timepoint: Efficacy will be assessed by : Clinical improvement in signs and symptoms such as, 1.Measuring reduction in the Pruritus with skin rash at week 1 and 2 2.Measuring reduction in skin lesions (change in the size, number and morphology) at week 1 and 2 Safety will be assessed by: Number and severity of adverse events. | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDrGeetha A
Bangalore medical college and research institute bangalore
Outcome results
None listed